Authors:
Andrews, JL
Kadan, MJ
Gorziglia, MI
Kaleko, M
Connelly, S
Citation: Jl. Andrews et al., Generation and characterization of E1/E2a/E3/E4-deficient adenoviral vectors encoding human factor VIII, MOL THER, 3(3), 2001, pp. 329-336
Authors:
Bristol, JA
Gallo-Penn, A
Andrews, J
Idamakanti, N
Kaleko, M
Connelly, S
Citation: Ja. Bristol et al., Adenovirus-mediated factor VIII gene expression results in attenuated anti-factor VIII-specific immunity in hemophilia a mice compared with factor VIII protein infusion, HUM GENE TH, 12(13), 2001, pp. 1651-1661
Authors:
Slosberg, ED
Desai, UJ
Fanelli, B
Denny, IS
Connelly, S
Kaleko, M
Boettcher, BR
Caplan, SL
Citation: Ed. Slosberg et al., Treatment of type 2 diabetes by adenoviral-mediated overexpression of the glucokinase regulatory protein, DIABETES, 50(8), 2001, pp. 1813-1820
Authors:
Desai, UJ
Slosberg, ED
Boettcher, BR
Caplan, SL
Fanelli, B
Stephan, Z
Gunther, VJ
Kaleko, M
Connelly, S
Citation: Uj. Desai et al., Phenotypic correction of diabetic mice by adenovirus-mediated glucokinase expression, DIABETES, 50(10), 2001, pp. 2287-2295
Authors:
Gallo-Penn, AM
Shirley, PS
Andrews, JL
Tinlin, S
Webster, S
Cameron, C
Hough, C
Notley, C
Lillicrap, D
Kaleko, M
Connelly, S
Citation: Am. Gallo-penn et al., Systemic delivery of an adenoviral vector encoding canine factor VIII results in short-term phenotypic correction, inhibitor development, and biphasic liver toxicity in hemophilia A dogs, BLOOD, 97(1), 2001, pp. 107-113
Authors:
Bristol, JA
Shirley, P
Idamakanti, N
Kaleko, M
Connelly, S
Citation: Ja. Bristol et al., In vivo dose threshold effect of adenovirus-mediated Factor VIII cone therapy in hemophiliac mice, MOL THER, 2(3), 2000, pp. 223-232
Authors:
Roy, S
Shirley, PS
Connelly, S
Andrews, JL
Kayda, DB
Gardner, JM
Kaleko, M
Citation: S. Roy et al., In vivo evaluation of a novel epitope-tagged human factor VIII-encoding adenoviral vector, HAEMOPHILIA, 5(5), 1999, pp. 340-348
Authors:
Andrews, JL
Weaver, L
Kaleko, M
Connelly, S
Citation: Jl. Andrews et al., Efficient adenoviral vector transduction and expression of functional human factor VIII in cultured primary human hepatocytes, HAEMOPHILIA, 5(3), 1999, pp. 160-168
Authors:
Gallo-Penn, AM
Shirley, PS
Andrews, JL
Kayda, DB
Pinkstaff, AM
Kaloss, M
Tinlin, S
Cameron, C
Notley, C
Hough, C
Lillicrap, D
Kaleko, M
Connelly, S
Citation: Am. Gallo-penn et al., In vivo evaluation of an adenoviral vector encoding canine factor VIII: High-level, sustained expression in hemophiliac mice, HUM GENE TH, 10(11), 1999, pp. 1791-1802
Authors:
Connelly, S
Andrews, JL
Gallo-Penn, AM
Tagliavacca, L
Kaufman, RJ
Kaleko, M
Citation: S. Connelly et al., Evaluation of an adenoviral vector encoding full-length human factor VIII in hemophiliac mice, THROMB HAEM, 81(2), 1999, pp. 234-239
Citation: S. Connelly, Redefining Shakespeare: Literary theory and theater practice in the GermanDemocratic Republic, THEAT SURV, 40(2), 1999, pp. 117-119